De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

HealthcareLtd Beheer

Beheer criteriumcontroles 4/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Zhang Gen Ni

Algemeen directeur

CN¥804.8k

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	12yrs
Eigendom CEO	34.0%
Management gemiddelde ambtstermijn	12yrs
Gemiddelde ambtstermijn bestuur	10.2yrs

Recente managementupdates

Recent updates

Market Participants Recognise Healthcare Co.,Ltd.'s (SHSE:603313) Earnings

Sep 26

HealthcareLtd's (SHSE:603313) Profits Appear To Have Quality Issues

Sep 06

CEO

Zhang Gen Ni (49 yo)

12yrs

Tenure

CN¥804,800

Compensatie

Mr. Zhang Gen Ni is Chairman of the Board & President of Healthcare Co., Ltd. since October 29, 2012. He was Chairman of the Board, General Manager and Director of Development Center of Healthcare Co., Ltd...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Zhang Gen Ni	Chairman of the Board & President	12yrs	CN¥804.80k	33.97% CN¥ 1.4b
Xiao Hong Wu	VP & Director	12yrs	CN¥441.40k	0.0053% CN¥ 215.3k
Hong Jian Zhang	VP & Director	12yrs	CN¥710.30k	0.0053% CN¥ 215.3k
Hailong Zhang	Accounting Supervisor	no data	geen gegevens	geen gegevens

12.0yrs

Gemiddelde duur

51yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 603313 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 12 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Zhang Gen Ni	Chairman of the Board & President	12yrs	CN¥804.80k	33.97% CN¥ 1.4b
Xiao Hong Wu	VP & Director	12yrs	CN¥441.40k	0.0053% CN¥ 215.3k
Hong Jian Zhang	VP & Director	12yrs	CN¥710.30k	0.0053% CN¥ 215.3k
Jian Long Ji	Director	8.4yrs	CN¥474.10k	0.0053% CN¥ 215.3k
Tao Lin	Employee Supervisor	12yrs	geen gegevens	geen gegevens
Hua Wei	Member of Supervisory Board	12yrs	geen gegevens	geen gegevens
Chang Ling Zhu	Independent Director	5.5yrs	CN¥80.00k	geen gegevens
Baiming Xu	Independent Director	5.5yrs	CN¥80.00k	geen gegevens
Zaifa Cai	Independent Director	5.5yrs	CN¥80.00k	geen gegevens
Jian Sun	Chairman of the Supervisory Board	7.8yrs	geen gegevens	geen gegevens

10.2yrs

Gemiddelde duur

52yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 603313 zijn ervaren en ervaren (gemiddelde ambtstermijn van 10.2 jaar).

HealthcareLtd Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Healthcare Co.,Ltd., Annual General Meeting, May 17, 2024

Healthcare Co.,Ltd., Annual General Meeting, May 17, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Healthcare Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 18%

Market Participants Recognise Healthcare Co.,Ltd.'s (SHSE:603313) Earnings

Price target decreased by 60% to CN¥5.30

HealthcareLtd's (SHSE:603313) Profits Appear To Have Quality Issues

Second quarter 2024 earnings released: EPS: CN¥0.065 (vs CN¥0.19 in 2Q 2023)

Now 22% overvalued

Healthcare Co.,Ltd. to Report First Half, 2024 Results on Aug 31, 2024

Healthcare Co.,Ltd., Annual General Meeting, May 17, 2024

Healthcare Co.,Ltd., Annual General Meeting, May 17, 2024

Healthcare Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024

New minor risk - Shareholder dilution

Healthcare Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024

New major risk - Financial position

Third quarter 2023 earnings released: EPS: CN¥0.031 (vs CN¥0.03 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.11 in 2Q 2022)

Now 20% undervalued

Price target decreased by 10% to CN¥12.68

First quarter 2023 earnings released: EPS: CN¥0.03 (vs CN¥0.06 in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.03 (vs CN¥0.59 loss in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.12 loss in 2Q 2021)

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to CN¥15.00

Less than half of directors are independent

Third quarter 2021 earnings released: CN¥0.59 loss per share (vs CN¥0.42 profit in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Price target decreased to CN¥29.93

Second quarter 2021 earnings released: CN¥0.12 loss per share (vs CN¥0.17 profit in 2Q 2020)

Investor sentiment deteriorated over the past week

Price target decreased to CN¥28.03

Price target increased to CN¥52.73

Full year 2020 earnings released: EPS CN¥1.11 (vs CN¥1.18 in FY 2019)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: CN¥43.05

New 90-day high: CN¥39.17

Investor sentiment improved over the past week

Market bids up stock over the past week

New 90-day high: CN¥36.87

Price target raised to CN¥46.61

Analysts update estimates

Healthcare Co., Ltd. to Report Q3, 2020 Results on Oct 31, 2020

Third quarter earnings released

Price target raised to CN¥36.16

Earnings released

New 90-day high - CN¥29.33

New 90-day high - CN¥26.83

Healthcare Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd